Life ScienceCompany
Ab Initio Biotherapeutics Ownership
Who owns Ab Initio Biotherapeutics?
Ab Initio Biotherapeutics is owned by Ligand Pharmaceuticals. It was acquired on July 23, 2019.
Ab Initio Biotherapeutics Business Overview
Where is Ab Initio Biotherapeutics headquartered?
Ab Initio Biotherapeutics is headquartered in San Francisco, California.
What sector is Ab Initio Biotherapeutics in?
Ab Initio Biotherapeutics is a life science company.
When was Ab Initio Biotherapeutics founded?
Ab Initio Biotherapeutics was founded in 2015.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Subscribe to Mergr to view all 252 acquisitions of life science companies in 2019, including 45 acquisitions by private equity firms, and 207 by strategics.
Unlimited Searches
